Corbion N.V. and Intrepid have collaborated to accelerate the development of long-acting injectable drug formulations using AI. Their joint effort combined Corbion's PURASORB polymer library with Intrepid Labs' AI algorithm, ANDROMEDA 1, to optimize drug loading, release kinetics, and other critical factors. This AI-driven approach successfully identified four promising candidate formulations within approximately 15 weeks, demonstrating a significant acceleration in the drug development process. AI
IMPACT AI-driven optimization significantly speeds up the identification of viable drug formulations, reducing development time and costs.
RANK_REASON The cluster describes a research paper detailing the application of AI in optimizing drug formulations. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →